許麗霞，女，住院醫(yī)師，博士，2008年畢業(yè)于中山大學臨床醫(yī)學系，獲醫(yī)學學士學位，同年被推薦免試到中山大學附屬醫(yī)院消化內(nèi)科攻讀碩士研究生，碩士期間赴香港中文大學威爾斯親王醫(yī)院消化疾病研究所做訪問學者；2014年于香港中文大學內(nèi)科及藥物治療系獲博士學位，主要研究方向為消化系統(tǒng)腫瘤（胃癌、結(jié)直腸癌、肝癌）的發(fā)病機制；博士期間赴澳洲國立大學做訪問學者，師從國際肝病醫(yī)生Geoff Farrell 教授。對消化系統(tǒng)常見疾?。ò晕秆?、消化性潰瘍、慢性肝病、功能性胃腸病等），尤其是消化系統(tǒng)腫瘤的診斷與治療有一定的臨床經(jīng)驗。業(yè)績：迄今為止共發(fā)表學術(shù)論文十多篇，其中包括以作者身份在Gut等專業(yè)國際學術(shù)期刊發(fā)表的論文2篇；多次在消化領(lǐng)域全球別學術(shù)會議DDW口頭匯報研究成果；獲得美國專利一項；2015年入選中山大學附屬醫(yī)院“青年人才支持計劃”。代表性論著：1.許麗霞，曾志榮，吳小琴，等?；|(zhì)金屬蛋白酶-9基因多態(tài)性與廣東地區(qū)胃癌的關(guān)系。胃腸病學. 2010; 15(12):713-6。2.許麗霞，曾志榮，于君。腫瘤控制基因啟動子區(qū)甲基化在胃癌中的功能意義及臨床價值。中華消化雜志. 2011; 31(4):286-88。3.曾志榮，吳小琴，許麗霞，等。白細胞介素-17F A7488G多態(tài)性與廣東地區(qū)胃癌的關(guān)系。中華消化雜志. 2010; 30(8):507-11。4.Xu L, Li X, Chu ES, et al. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival of gastric cancer. Gut 2012; 61(7):977-85. 5.Xu L, Li X, Cai M, et al. Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer. Gut Accepted. 6.Xu L, Zeng Z, Chen B, et al. Association between the TGFB1-509C/T and TGFBR2-875A/G polymorphisms and gastric cancer: a case-control study. Oncol Lett. 2011; 2:371-7. 7.Wang J, Dong L, Xu L, et al. B cell CLL/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice. Cancer Lett 2014,355(2):192-200. 8.Wu X, Zeng Z, Xu L, et al. Increased expression of IL17A in human gastric cancer and its potential roles in gastric carcinogenesis. Tumor Biol 2014,35(6):5347-56. 9.Yang Q, Gao J, Xu L, et al.?Promoter hypermethylation of BCL6B gene is a potential plasma DNA biomarker for gastric cancer. Biomarkers 2013; 18(8):721-5. 10.Zhao G, Xu L, Chu SH, et al. Establishment of an orthotopic transplantation tumor model of hepatocellular carcinoma in mice. World J Gastroenterol 2012,18(47):7087-92. 11.Chen B, Zeng Z, Xu L, et al. IL23R +2199A/C polymorphism is associated with decreased risk of certain subtypes of gastric cancer in Chinese: A case-control study. Cancer Epidemiol 2011;35(2):165-9. 12.Liu W, Li X, Chu ES, et al. Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway. Hepatology 2011;53(3):843-53. 13.Yu C, Yu J, Yao X, et al. Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing. Cell Res 2014 Jun;24(6):701-12. 14.Otani K, Dong Y, Li X, et al. Odd-skipped related 1 is a novel tumor suppressor gene and a potential prognostic biomarker in gastric cancer. J Pathol 2014,234(3):302-15. 15.Jiang L, Yang YD, Fu L, et al. CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma. Oncotarget 2014 Sep 15;5(17):7663-76.